Public Health Vaccines LLC
๐บ๐ธUnited States
Study to Evaluate the Recombinant Vesicular Stomatitis Virus (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects
Phase 1
Recruiting
- Conditions
- Marburg Virus Disease
- Interventions
- Biological: PHV01Biological: Placebo
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- Public Health Vaccines LLC
- Target Recruit Count
- 36
- Registration Number
- NCT06265012
- Locations
- ๐บ๐ธ
CenExel RCA, Hollywood, Florida, United States
Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects
Phase 1
Active, not recruiting
- Conditions
- Nipah Virus Infection
- Interventions
- Biological: Lactated Ringer's
- First Posted Date
- 2024-01-24
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Public Health Vaccines LLC
- Target Recruit Count
- 120
- Registration Number
- NCT06221813
- Locations
- ๐บ๐ธ
Cenexel ACT (Anaheim Clinical Trials), Anaheim, California, United States
๐บ๐ธCenexel JBR (JBR Clinical Research), Salt Lake City, Utah, United States
๐บ๐ธCenexel RCA (Research Centers of America), Hollywood, Florida, United States
A Phase 1 Study to Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects
- First Posted Date
- 2022-01-05
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Public Health Vaccines LLC
- Target Recruit Count
- 60
- Registration Number
- NCT05178901
- Locations
- ๐บ๐ธ
Johnson County Clin-Trials(JCCT), Lenexa, Kansas, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath